Signal Bureau What’s happening · what the record shows

Phase Ii

A topic on our watch list — we track its coverage across 6 domains, including Pubmed Targeted, Gi Journal and Preprint.

If Phase Ii is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.

What’s changed

A phase II study of alpelisib and capecitabine in patients with previously treated metastatic colorectal cancer (KCSG-CO21-04). · Sci Rep · 2026-06-29
Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial. · Clin Cancer Res · 2026-07-23
EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA · Future Oncol · 2026-06-25

Ask the engine about Phase Ii ＋ Track Phase Ii for a daily read

Informational only — not financial, legal, or investment advice. Prediction-market prices are shown as a signal of what the crowd believes. Terms · Privacy · page rendered Jul 28, 8:27 AM PT